NCT03108053

Brief Summary

Up-to-date, urology guidelines introduce safety guidewire (SGW) as an integral tool in ureteroscopy and recommended its routine use. However, the necessity of SGW placement in endourological procedures lack evidence and is being suggested as an expert opinion. Present study aimed to evaluate the use of SGW placement and its necessity in treatment of ureteral stones with semi-rigid ureteroscopy (s-URS). For this purpose patients with ureteral stones are being stratified according to ureteral stone location and prospectively randomized into two groups' according to SGW usage or not in s-URS. Ureteroscopy and litotripsy is being done with a semi-rigid ureteroscope of 6.4/7.8 Fr (Olympus) and laser. Chi-square and student t-test were used for comparing data.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

March 10, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 11, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

March 19, 2019

Status Verified

March 1, 2019

Enrollment Period

5.5 years

First QC Date

March 10, 2017

Last Update Submit

March 17, 2019

Conditions

Keywords

urinary stonessemirigid ureteroscopyguidewire

Outcome Measures

Primary Outcomes (1)

  • Stone free rates

    Post operative 3 months (12 weeks after surgery)

Secondary Outcomes (3)

  • Operation duration of surgery

    the duration of surgical procedure

  • Late Complication rate

    Post operative 3 months (12 weeks after surgery)

  • Early Complication rate

    Post operative 3 days (up to 3 days after surgery)

Study Arms (2)

Guidewire used

ACTIVE COMPARATOR

Patients whose semirigid ureteroscopy procedure is conducted with the use of safety guidewire

Procedure: Semirigid Ureteroscopy (URS) With Guide Wire

No guide wire used

EXPERIMENTAL

Patients whose semirigid ureteroscopy procedure is conducted without the use of safety guidewire

Device: Semirigid Ureteroscopy (URS) Without Guide Wire

Interventions

Semirigid URS is the operations used for ureteral stone disease. In routine practice it is most commonly done with the use of a guide wire. It is conducted with ureteroscope and stone is disintegrated most commonly with lasers.

Guidewire used

Semirigid URS is the operations used for ureteral stone disease . It is conducted with ureteroscope and stone is disintegrated most commonly with lasers.

No guide wire used

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ureteral stone disease patients who would undergo ureteroscopy procedure

You may not qualify if:

  • Patients who have a medical condition that makes randomisation not possible
  • Patients in whose operations safety guidewire is regarded as a necessity
  • Patients who refuse to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University School of Medicine

Pendik, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Urinary Calculi

Condition Hierarchy (Ancestors)

UrolithiasisUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2017

First Posted

April 11, 2017

Study Start

June 1, 2014

Primary Completion

December 1, 2019

Study Completion

January 1, 2020

Last Updated

March 19, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations